Drug-device Combination Products Market: Introduction

According to the report, the global drug device combination products market was valued at US$ 120.0 Bn in 2020 and is projected to expand at a CAGR of 7.3% from 2021 to 2028. Drug-device combination products are defined as therapeutic products comprising an active pharmaceutical ingredient and a medical device that are physically and/or chemically combined to be produced as a single product.

Increase in incidence of chronic diseases such as diabetes, cancer, and respiratory problems; rise in casualties due to accidents & trauma, surge in the geriatric population, growth of the home-based healthcare market, and technological advancements such as the development of prefilled syringes boost the growth of the global drug-device combination products market.

Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=153 

Rise in Prevalence of Chronic Diseases to Dominate Global Market

The increase in prevalence of chronic diseases and disorders such as cancer, cardiac conditions, multiple sclerosis, and diabetes is expected to fuel the growth of the global market over the next few years. According to the National Center for Biotechnology Information (NCBI), ischemic heart disease affected around 126 million people (1,655 per 100,000) in 2017, accounting for 1.72% of the global population.

Get Custom Research Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=153

Transdermal Patches to be Highly Lucrative Segment

In terms of product, the global drug device combination products market has been classified into drug eluting stents, infusion pumps, photosensitizers, orthopedic combination products, wound care combination products, inhalers, transdermal patches, and others. Transdermal patches are the most popular products. This is due to increase in demand for self-administered drugs for diseases that require long-term treatment. Insulin, for instance, must be administered intravenously to diabetic patients on a regular basis. Repeated use of injections to deliver insulin causes pain and increases the risk of infection transmission. Hence, alternative drug delivery modes are expected to gain popularity.

Enquiry Before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=153

North America to Dominate Global Market

In terms of region, the global drug device combination products market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to be a highly lucrative market for drug-device combination products during the forecast period. Increase in presence of patented nanomedical products across the region is a major factor driving the market. North America dominated the global drug-device combination products market in terms of revenue in 2020, and the trend is expected to continue during the forecast period.

Asia Pacific is likely to be the most lucrative market for drug-device combination products during the forecast period due to increase in incidence of cardiovascular diseases, diabetes-related disorders, and obesity.

Get Report Methodology @ https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=153

Competition Landscape

The global drug device combination products market is fragmented in terms of number of players. Key players in the global market include Teva Pharmaceutical Industries Ltd., AbbVie, Inc., Abbott Laboratories, Medtronic plc, Kaleo, SINOMED, Alcon, Inc., Boston Scientific Corporation, Integer Holdings Corporation, Teleflex Incorporated, Bausch Health Companies, Inc., Haselmeier GmbH, and Flowonix Medical, Inc.

More Trending Reports by Transparency Market Research:

Myopia and Presbyopia Treatment Market- https://www.prnewswire.com/news-releases/orthopedic-devices-market-witnessing-steady-demand-from-minimally-invasive-surgeries-tmr-study-301672779.html

Veterinary Endoscopes Market- https://www.globenewswire.com/en/news-release/2022/11/14/2555045/0/en/Veterinary-Endoscopes-Market-to-Gain-Value-of-US-846-0-Mn-by-2027-States-TMR-Study.html

Parenteral Nutrition Market- https://www.biospace.com/article/parenteral-nutrition-market-parenteral-lipid-emulsions-to-propel-the-market-tmr/

About Us 

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.


See Campaign: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1534

Contact Information:

Rohit Bhisey Transparency Market Research Inc. CORPORATE HEADQUARTER DOWNTOWN, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453

Reportedtimes, Financial Content, Extended Distribution, iCN Internal Distribution, Research Newswire, English